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Abstract:
The detection of differentially expressed (DE) genes, that is, genes whose expression
levels vary between two or more classes representing different experimental conditions
(say, diseases) is one of the most commonly studied problems in bioinformatics. For
example, the identification of DE genes between distinct disease phenotypes is an
important first step in understanding and developing treatment drugs for the disease.
It can also contribute significantly to the construction of a discriminant rule (classifier)
for predicting the class of origin of an unclassified tissue sample from a patient. We
present a novel approach to the problem of detecting DE genes that is based on a
test statistic formed as a weighted (normalized) cluster-specific contrast in the mixed
effects of the mixture model used in the first instance to cluster the gene profiles
into a manageable number of clusters. The key factor in the formation of our test
statistic is the use of gene-specific mixed effects in the cluster-specific contrast. It
thus means that the (soft) assignment of a given gene to a cluster is not crucial.
This is because in addition to class differences between the (estimated) fixed effects
terms for a cluster, gene-specific class differences also contribute to the cluster-specific
contributions to the final form of the test statistic. The proposed test statistic can
be used where the primary aim is to rank the genes in order of evidence against the
null hypothesis of no DE. We also show how a P -value can be calculated for each
gene for use in multiple hypothesis testing where the intent is to control the false
discovery rate (FDR) at some desired level. With the use of real and simulated data
sets, we show that the proposed contrast-based approach outperforms other methods
commonly used for the detection of DE genes both in a ranking context with lower
proportion of false discoveries and in a multiple hypothesis testing context with higher
power for a specified level of the FDR.
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1 Introduction
In the analysis of multivariate feature data from samples in m known classes of p
objects, one of the major goals is the inference on differences in observations between
classes. This leads to the identification of relevant features that differentiate the
classes and the prediction of the class of origin for unclassified objects. An example
of such an application is the analysis of gene-expression data, where the aim is to
detect genes (features) that are differentially expressed (DE) in a known number
m of classes (conditions), C1, . . . , Cm. These m classes may correspond to tissues
(cells) that are at different stages in some process or in distinct pathological states.
For example, one can compare healthy cells to cancerous cells to learn which genes
tend to be over- or under-expressed in the diseased cells. In this context, the intent
is also to select a small subset of “marker” genes that characterize the different tissue
classes and construct a classifier to predict the class of origin of an unclassified tissue
sample with respect to one of a number of distinct disease phenotypes [1]. Studies
on breast and other tumours suggested that classifiers based on a small set of marker
genes can better classify tumour subtypes than can standard clinical criteria [2].
An obvious test statistic to employ in the detection of DE for a given gene is to
form the usual two-sample (pooled) t-test statistic. However, as small class-sample
sizes are often used for microarray experiments, there can be problems with a poor
estimate of the variance in the denominator of the t-statistic if each gene is considered
independently. One attempt ‘at borrowing strength’ across the tests is to adopt a
moderated form of the t-statistic whereby the gene-specific variance is weighted with a
contribution from all the genes; for example, [3]. Another commonly used attempt to
involve all the gene profiles in the formation of a test statistic for a gene is to partition
the gene profiles into clusters [4, 5, 6]. Existing clustering-based methods have been
implemented by assuming the existence of pure clusters of up- and down-regulated
genes, which are reflected by large class differences in the cluster-specific (estimated)
mean expressions for the tissues [7, 8]. In an ideal situation, there would be three
clusters corresponding to null genes, upregulated-DE genes, and down-regulaetd DE
genes. But in practice, there is a need for more than three clusters since not all the up-
regulated genes are assigned to the one cluster and, similarly, for the down-regulated
genes. With more than three clusters there is the problem of how to identify the
clusters corresponding null genes and up- and down-regulated DE genes, assuming
the clusters are pure [9]. One way of approaching this problem has been to adopt
an hierarchical approach whereby each cluster is decomposed into three subclusters
representing null, up-regulated DE, and down-regulated genes [10].
Given pure clusters, the question of whether a gene is DE is decided on the basis
of its (estimated) posterior probabilities of membership with respect to the various
clusters. However, the intent of obtaining pure clusters is not always possible or
verifiable. For example, a gene might have a high estimated posterior probability of
belonging to a cluster taken to correspond to DE genes. But it can still be quite
atypical of the cluster to which it is assigned and, indeed, be a null gene as to be
illustrated below. The cluster-specific contrasts for tests on differences between the
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classes are the same for all genes in a cluster if no gene-specific differences are incldued
in the contrast. They thus can be misleading.
In our approach, we therefore include gene-specific random effects terms in forming
a cluster-specific contrast. Our initial clustering of the gene profiles into a number g
of clusters is effected by the fitting of a mixture of linear mixed models (LMMs) that
include random effects terms specific to the genes in addition to the class-specific
fixed effects terms. This model extends earlier work of [11] by allowing correlated
gene-specific random effects for the m tissue classes to follow a multivariate normal
distribution, which gives a more flexible model with an additional correlation param-
eter explicitly governing and accounting for the relationship between gene expressions
among the tissue classes due to individual gene effects; see Section 2. The component
LMMs also include random effects terms shared by all genes belonging to the same
component of the mixture model, which implies that these genes are not assumed to
be independently distributed as usually assumed in other clustering or multiple hy-
pothesis testing approaches; see also [12], [13], and [14]. The choice of the number g of
clusters is made by consideration of the likelihood via the BIC criterion [15]. However,
the choice of g is not crucial in that the subsequent use of them in our approach does
not rely on the clusters being pure as to whether all cluster members are DE or not
DE (null). In our approach, a (normalized) contrast for the test of no DE is formed
based on class differences between the cluster-specific fixed effects terms for each
class in addition to class differences between the gene-specific random effects terms.
As discussed below, the inclusion of the latter terms in the cluster-specific contrast
means that a gene not typical of the cluster to which has been assigned outright or in
a soft manner by the initial clustering of the genes can modify the differences between
the fixed effects terms for the cluster. The final form of our proposed test statistic
is formed by weighting the cluster-specific (normalized) contrasts over the clusters.
The test statistic can be used to rank the genes in order of evidence against the null
hypothesis of no DE, which is often the primary aim of gene discovery experiemntns
for which microarrays are designed. The distributional assumptions do not have to
hold for the test statistic to peform well in ranking the genes. Our proposed test
statistic can be used also to carry multiple hypothsis testing [16] where the intent is
to control the false discovery rate (FDR) at or below a specified level; see also [17]
and [18]. In the case of calculating the P -value, we adopt a permutation approach
to provide an approximation to the null distribution of the test statistic and hence
to the calculation of the associated P -value. The FDR can be controlled by using
the [19] procedure or by, say, converting the P -vlaues for the genes to z-scores and
then fitting mixtures of normal densities to these z-scores to obtain an estimate of
the local false discovery rate in the form of the posterior probability that a gene is
null given its z-score [20].
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2 The model
We let ph be the number of samples in the hth tissue class Ch (h = 1, . . . , m).
The total number of measurements for each gene is p =
∑m
h=1 ph. Thus the gene-
expression data can be represented by a n × p matrix, where n is the number of
genes. We let yj = (y1j , . . . , ypj)
T contain the measurements on the jth gene, where
superscript T denotes vector transpose; that is, yj is the gene profile vector for
the jth gene (j = 1, . . . , n). It is postulated that yj has a g-component mixture
distribution with probability pii of belonging to the ith component Gi (i = 1, . . . , g),
where the pii sum to one. We let the g-dimensional vector zj denote the component
membership of yj, where zij = (zj)i = 1 if yj belongs to the ith component and zero
otherwise (i = 1, . . . , g). We put y = (yT1 , . . . , y
T
n )
T and z = (zT1 , . . . , z
T
n )
T .
Conditional on its membership of the ith component Gi, the distribution of yj is
specified by the LMM [21]
yj = Xβi + Ubij + V ci + ²ij, (1)
where X, U , and V denote the design matrices corresponding, respectively, to the
fixed effects terms βi and to the random effects terms bij and ci (i = 1, . . . , g).
The vector bij = (b1ij , . . . , bmij)
T contains the gene-specific random effects for
each of the m tissue classes, and ci = (c1i, . . . , cpi)
T contains the random effects
common to all genes from the ith component. The latter induces a correlation between
those genes from the same component and is an attempt to allow for the fact that in
reality the gene profile vectors are not all independently distributed. The gene-specific
random effects bhij (h = 1, . . . , m) allow for correlation between the gene expressions
across the tissues both within a class and between classes for the same gene. The
expressions on a given gene should be independent but this may not hold in practice
due to poor experimental conditions resulting in batch-effects.
The measurement error vector ²ij is taken to be multivariate normal Np(0, Ai),
where Ai is a diagonal matrix. The vectors bij and ci of random effects terms are
taken to be multivariate normal Nm(0, Bi) and Np(0, Ci), respectively, where C i is
assumed to be diagonal and Bi is a non-diagonal matrix given by
Bi =

σ2b1i ρσb1iσb2i · · · ρσb1iσbmi
ρσb2iσb1i1 σ
2
b2i · · · ρσb2iσbmi
...
...
...
...
ρσbmiσb1i ρσbmiσb2i · · · σ2bmi
 , (2)
where the additional parameter ρ accounts for the correlation between gene-specific
random effects bhij (h = 1, . . . , m), which are shared, respectively, among the expres-
sions on the jth gene in the hth tissue class (see Supplementary materials for the
covariance structure of the unconditional distribution of the gene-expression profiles
under (1) and (2)).
4
2.1 The test statistic
We now define our test statistic for the ranking of the genes in order of their signif-
icance of being differentially expressed. We proceed initially under the assumption
that each gene profile is classified with respect to the g components G1, . . . , Gg in its
mixture distribution with components specified by (1); that is z is known. We also
assume initially that the vector ζ i containing the distinct elements in the component-
covariance matrices Ai, Bi, and Ci, is known.
We let bGi be the (mni)-dimensional vector containing the random effects terms
for the ni genes belonging to the ith component of the mixture model (i = 1, . . . , g).
We can write bGi as
bGi = (b
T
i1 , . . . , b
T
ini
)T , (3)
where i1, . . . , ini denote the labels of the ni genes belonging to the ith component
Gi (i = 1, . . . , g) of the mixture model.
We let
ri = (β
T
i , b
T
Gi
, cTi )
T (i = 1, . . . , g) (4)
be the vector containing the fixed and random effects for the ni genes belonging to
the ith component Gi (i = 1, . . . , g). For an individual gene j belonging to the ith
component Gi, we can form the cluster-specific normalized contrast Sij given by
Sij = d
T
j ri/λij (i = 1, . . . , g), (5)
where dj is a vector whose elements sum to zero and λij is the normalizing term. The
choice of dj has direct implication on the inference space of the contrast Sij. For the
case of m=2 classes of tissue samples, a typical form for dj is
dTj = (1 -1
... 0 0, . . . , 0 0, 1 -1, 0 0, . . .
... 0 . . . 0), (6)
where only one pair of (1 -1) exists in the second partition corresponding to the gene-
specific random effects bij for a gene in the ith cluster. The contrast (6) represents an
“intermediate inference space” in that the inference is “narrow” to gene-specific ran-
dom effects bij but “broad” to tissue-specific random effects ci [22]. This means that
a contrast of differential expressions between two classes of tissues is being considered
and the inference applies to the specific genes studied in the experiment (narrow) and
to the entire population from which biological tissue samples were obtained (broad).
Our proposed test statistic is based on an estimate Sˆij of Sij obtained by replacing
ri with an estimate rˆi in the right-hand side of (5) and now taking the normalizing
term λij to be the standard error of d
T
j rˆi (conditional on membership of the jth gene
to the ith component Gi). That is,
Sˆij = d
T
j rˆi/λij, (7)
where rˆi is an estimate of the vector ri of fixed and random effects terms and
λij =
√
dTj cov(rˆi)dj. (8)
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In the case where rˆi is the BLUP estimator of ri,
cov(rˆi) = Ωi(ζi; z), (9)
where Ωi is defined as follows.
The matrix Ωi (and dj) is partitioned conformally corresponding to βi|bGi|ci with
dimensions m, mni, and p, respectively. That is,
Ωi =
 Ωiβ Ωiβb ΩiβcΩTiβb Ωib Ωibc
ΩTiβc Ω
T
ibc Ωic

−1
, (10)
where Ωiβ = niX
T A−1i X, Ωiβb = 1ni ⊗XT A−1i U ,
Ωiβc = niX
T A−1i V , Ωib = Ini ⊗ (UT A−1i U + B−1i ),
Ωibc = 1ni ⊗UT A−1i V , Ωic = ni(V T A−1i V + C−1i ), (11)
where 1ni is a ni-dimensional vector of ones, Ini is an identity matrix with dimension
ni, and the sign ⊗ denotes the Kronecker product of two matrices.
The computation of the inverse matrix (10) is not straightforward as the partition
corresponding to bGi involves a large dimensional block matrix (see the Supplementary
materials for the derivation of the inverse matrix (10) in terms of (11)). In evaluating
Ωˆi in (10), it is noted that the empirical approximation, using the maximum likelihood
(ML) estimates (Aˆi, Bˆi, Cˆi), tends to underestimate the true sampling variability of
the estimated contrast Sˆij of mixed effects. It is because the uncertainty in estimating
the variance components is not accounted for. Based on a nonparametric bootstrap
method [23], we found that the variances of the variance component estimates are
generally small (contributing less than 5% of variance component estimates). Thus,
the use of estimated variance components does not appear to introduce a large bias
on Ωˆi; see [22].
Now in practice we do not know the classification z of the gene profiles with
respect to the g components G1, . . . , Gg nor the vector ζi of variances/covariances.
We therefore fit a mixture of g-component LMM distributions as defined by (1) with
the value of g is chosen according to the BIC criterion. The vector Ψ containing
the unknown mixing proportions pii, the fixed effects βi, and the vector ζi of vari-
ances/covariances (i = 1, . . . , g) is estimated by ML. The random effects terms bGi
and ci are estimated by bˆGi = EΨ̂
{bGi | yj, zij = 1} and cˆi = EΨ̂{ci | y}, respec-
tively, where E
Ψ̂
denotes expectation using Ψ̂ for Ψ. For unknown ζi and z, we
make the approximation
cov(rˆi) ≈ Ωi(ζ̂i, zˆ); (12)
see the Supplementary materials for the justification of this approximation.
Conditional on membership of the jth gene from component Gi, this leads to the
estimated (normalized) contrast,
Sˆij = d
T
j rˆi/
√
dTj Ωi(ζ̂i; zˆ)dj, (13)
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where
rˆi = (βˆ
T
i , bˆ
T
Gi
, cˆTi )
T . (14)
On weighting now the estimated (normalized) contrast Sˆij over the g components in
the mixture model, we obtain as our test statistic for the jth gene,
Wj =
g∑
i=1
τi(yj; Ψ̂, cˆi) Sˆij, (15)
where τi(yj; Ψ, ci) is the posterior probability that the jth gene belongs to the ith
component Gi conditional on yj and ci.
2.2 Null Distribution of Wj
The weighted contrast Wj can be formed to test the null hypothesis of Hj : jth
gene is not DE (j = 1, . . . , n). The null distribution of Wj can be assessed using a
permutation method described as follows. The steps are:
1. Let H be the n × p data matrix, where H = (y1 · · · yn)T . Permute the class
labels B times (corresponding to the p columns of H) and let y
(b)
j be the gene
profile for the jth gene after the bth permutation (b = 1, . . . , B; j = 1, . . . , n).
Then after the bth permutation we have corresponding to H, the data matrix
H(b) = (y
(b)
1 · · · y(b)n )T .
2. Then for each gene j in turn, compute the B replications W
(b)
j of Wj (b =
1, . . . , B), where W
(b)
j is calculated in the same way that Wj is calculated
except that yj is replaced by y
(b)
j . That is, at the end of the estimation process
for the original data H, we compute the Wj. Now to compute the W
(b)
j we
repeat the last process but with H replaced by H (b).
As stated above, it follows from (13) to (15) that W
(b)
j is given by
W
(b)
j =
g∑
i=1
τi(y
(b)
j ; Ψ̂, cˆi)Sˆ
(b)
ij , (16)
where
Sˆ
(b)
ij = d
T
j rˆ
(b)
i /
√
dTj Ωi(ζ̂i; zˆ)dj (17)
and where
rˆ
(b)
i = (βˆ
T
i , bˆ
(b)T
Gi
, cˆTi )
T . (18)
In (18), we have
bˆ
(b)
Gi
= E
Ψ̂
{bGi | y(b)j , zij = 1}. (19)
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Figure 1: Three selected gene profiles (7 BRCA1- and 8 BRCA2-mutation-positive
tumour tissue samples): Solid line (from Cluster 3, βˆ13 − βˆ23 = 0.303, difference
in gene-specific random effects bˆ13j − bˆ23j = 0.646); Dashed line (from Cluster 4,
βˆ14−βˆ24 = 0.047, bˆ14j−bˆ24j = 0.487); Dotted line (from Cluster 1, βˆ11−βˆ21 = −0.351,
bˆ11j − bˆ21j = 0.387).
2.3 Data Preprocessing
In practice, it is common to standardize each column of the data matrix to have
zero mean and unit standard deviation, followed by the row standardization to shift
expression profiles to the same baseline (zero mean, unit standard deviation) for com-
parison. However, row standardization will transform the data into directional data
that lie on a unit hypersphere [24]. The latter implies that multivariate normal dis-
tributions may not be appropriate for modelling row-standardized gene-expression
profiles of high dimensions [25]. In this paper, data preprocessing is implemented
by column standardization only, which helps to standardize the variability of gene
expressions for each tissue sample and hence facilitates the clustering of genes. With-
out row standardization, it implies that genes with different mean expressions shall
be clustered into different clusters, despite the fact that they may exhibit similar
differentiation across the tissue classes. In other words, genes within the same cluster
shall have different patterns of differential expression. A cluster of genes may there-
fore contain both DE and non-DE genes; see Section 3. This is consistent with the
approach presented in [10] where three patterns of differential expression are nested
within a mixture model.
3 Results
Using three published gene-expression data sets, we first show how the proposed
method can be used to detect DE genes between two tissue classes. Results are pre-
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sented for functional annotation and enrichment analysis of those top-ranked genes.
We then compare our method with different approaches using a benchmark data set
in terms of the false discovery proportion [26] for the top ranked genes. Additional
empirical studies using simulated data are also performed to illustrate advantages of
our method compared to existing methods applied in a multiple hypothesis testing
context with the FDR controlled at a specified level.
3.1 Identification of differentially-expressed genes
We applied the clustering-based contrast method to the breast cancer dataset of [27].
The data comprised the measurement of 3226 genes using cDNA arrays, for p1=7
BRCA1-mutation-positive tumours and p2=8 BRCA2-mutation-positive tumours. The
aim is to identify DE genes between the tumours associated with the different muta-
tions. We column normalized the logged expressions and fitted the proposed extended
random-effects model to the data with g=3 to g=15 clusters. Using BIC, we identified
five clusters of genes (see Supplementary materials for details of the clustering results
including the ML estimates of the unknown parameters). The difference βˆ1i − βˆ2i
between the estimated mean expressions in Class 1 and Class 2 for the ith component
are -0.351, -0.131, 0.303, 0.047, and -0.147 for i = 1, . . . , 5, respectively. However,
it is not necessary all genes in the clusters with large absolute differences βˆ1i − βˆ2i
(such as for i = 1 or 3) are DE. On the other hand, a DE gene j may be grouped into
Cluster 4, but can have a large weighted contrast due to a large difference | bˆ1ij− bˆ2ij |
between the (estimated) gene-specific random effects terms for i=4. As an illustra-
tion, we depict in Figure 1 three gene profiles. Two of them are among the top 100
ranked genes, but one is from Cluster 3 (large absolute difference | βˆ13 − βˆ23 |) and
the other is from Cluster 4 (small absolute difference | βˆ14 − βˆ24 |). The remaining
gene profile may correspond to a non-DE gene which, however, would be assigned
to Cluster 1 with large absolute difference | βˆ11 − βˆ21 |) (see also Supplementary
materials, Table S2).
The ranking of DE genes is implemented on the basis of the weighted estimates of
contrast of mixed effects (15). The top 50 ranked up-regulated genes (corresponding
to large negative weighted contrast) and the top 50 down-regulated genes (corre-
sponding to large positive weighted contrast) in BRCA2-mutation-positive tumours
relative to tumours with BRCA1 mutations are presented for functional annotation
and enrichment analyses, using web-based DAVID Functional Annotation Tool [28]
and GeneGo MetaCore pathway analysis program.
3.2 Functional annotation and enrichment analyses
We compare our clustering-based contrast method with a multiple hypothesis testing
approach that is based on the pooled two-sample t-statistic [2, 29]. The gene lists
obtained by both methods (contrast and t-test methods) were submitted to DAVID
Bioinformatics Resources 6.7 for Functional Annotation analyses. Gene Ontology
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(GO) terms with the most significant gene enrichment statistics were selected for
each method and compared. The same gene lists with mean expression values were
also evaluated by “compare experiment” module of the GeneGo MetaCore pathway
analysis tool (Thomson Reuters, St. Joseph, MI) for reports of common and unique
networks identified by the two methods.
The results of the functional annotation and enrichment analyses by DAVID Func-
tional Annotation Tool are presented in Table 1. It can be seen that our top-ranked
genes are involved in more annotated functions with slightly higher significance. In
the analysis by [27], coordinated transcription activation of genes involved in DNA
repair and induction of apoptosis was found in tumours with BRCA1 mutations, and
genes involved in suppression of apoptosis in tumours with BRCA2 mutations (as
reference). Our clustering-based contrast method has identified these characteristics
in BRCA1- and BRCA2-mutation-positive tumours, respectively. In addition, our
method has also identified up-regulated genes involved in new significant pathways
represented by GO terms such as “blood vessel morphogenesis” and “response to
wounding” in tumours with BRCA2 mutations, as well as “regulation of mRNA sta-
bility” and “cellular protein metabolic processes” in tumours with BRCA1 mutations.
We has also used GeneGo MetaCore pathway analysis tool to compare network en-
richment of genes identified by the two methods (see Supplementary materials, Table
S3). The genes identified by the contrast method show significant enrichment in genes
that regulate cell cycle and cell adhesion functions. These new findings may provide
further insights into the differences between BRCA1- and BRCA2-mutated tumours.
Another illustration using the breast cancer dataset of [30] is given in the Supple-
mentary materials.
3.3 Golden Spike benchmark dataset
Golden Spike is a dataset generated to provide a benchmark for comparing different
approaches for the analysis of Affymetrix GeneChips [31]. The experiment compared
two classes of tissue samples: p1 = 3 (control) and p2 = 3 (spike-in). By design,
the data set has 1331 (9.5%) DE (nonnull) genes (nominal spike-in to control ratio
> 1) and 12666 (90.5%) true nulls (nominal spike-in to control ratio = 1 or do
not matched to any cRNA). In this study, the log-transformed data set “10a” is
used, which is available in the website of [31]; see also [32]. We fitted the extended
random-effects model to the data and identified four clusters of genes based on BIC
for model selection. Figure 2 presents the proportion of true nulls among the top-
ranked genes at various cut-off rankings. We compare our method with existing
approaches including Significance Analysis of Microarray (SAM) [29], Linear Models
for Microarray Data (LIMMA) [3], Optimal Discovery Procedure (ODP) [33], and
the t-test. From Figure 2, it can be seen that the proposed method outperforms the
other approaches by having the smallest proportion of true nulls when the cut-off
ranking is larger than 700. When the cut-off ranking is small, the proposed method
performs equally well as ODP. Among the top 1000 ranked genes (declared to be DE),
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Table 1: Comparison of GO term association of the top 50 ranked up- and down-
regulated genes in tumours with BRCA2 mutations relative to tumours with BRCA1
mutations (breast cancer data of [27])
contrast t-test
GO terms associated with up-regulated genes ct (fold) P -value ct (fold) P -value
Response to hormone stimulus 9 (7.9) 1.2E-05 6 (5.5) 3.9E-03
Cell motion 8 (5.4) 5.0E-04 3 (2.1) 4.0E-01
Enzyme linked receptor protein signal pathway 7 (6.6) 5.3E-04 6 (5.9) 2.9E-03
Regulation of cell proliferation 9 (3.7) 2.2E-03 8 (3.4) 6.6E-03
Regulation of phosphorylation 7 (4.8) 2.6E-03 5 (3.6) 4.4E-02
Transcription factor binding 7 (4.5) 3.5E-03 4 (2.7) 1.7E-01
Negative regulation of cell differentiation 5 (7.5) 4.0E-03 4 (6.3) 2.4E-02
Cell-matrix adhesion 3 (11) 3.0E-02 4 (15) 2.1E-03
Response to drug 7 (10) 4.4E-05
Negative regulation of apoptosis 7 (6.4) 6.4E-04
Blood vessel morphogenesis 5 (7.6) 3.7E-03
Response to wounding 7 (4.3) 4.9E-03
Cellular response to stress 6 (3.7) 2.2E-02
GO terms associated with down-regulated genes
Interphase of mitotic cell cycle 6 (18) 1.6E-05 6 (17) 2.2E-05
Cyclin-dependent protein kinase activity 5 (29) 2.3E-05 4 (22) 7.6E-04
Nuclear lumen 13 (4) 1.6E-04 13 (3) 7.0E-04
Posttranscriptional regulation - gene expression 6 (9.0) 4.7E-04 5 (7.0) 5.2E-03
Regulation to DNA damage stimulus 6 (5.1) 5.7E-03 9 (7.1) 2.7E-05
Induction of apoptosis 3 (3.0) 2.6E-01 5 (4.6) 2.1E-02
Regulation of mRNA stability 3 (43) 2.1E-03
Cellular protein metabolic process 5 (8.7) 2.3E-03
Single-stranded DNA binding 5 (28) 2.6E-05
Note: ct is the number of genes belonging to an annotation term, fold is the fold-enrichment
of involved genes over total genes in the list relative to the number of genes with the same
term category in the human genome background, P -value is the modified Fisher exact
P -value for assessing the gene-enrichment; see [28]
our method gives the least of 79 true nulls. The numbers of true nulls for the other
approaches are, respectively, 311 (SAM), 141 (SAM with its fudge factor s0 set to
zero), 290 (LIMMA), 227 (t-test), and 140 (ODP).
3.4 Simulation experiment 1: ranking of correlated genes
We consider the simulation procedure described in [34] to investigate the relative
performance of the contrast method when gene expressions are correlated. For m=2
classes of tissues with p1=p2=10, we generated 3000 gene expression levels indepen-
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Figure 2: Proportion of true nulls among the top-ranked genes.
dently for each of the 20 tissues in six blocks of size 500 from multivariate normal
distributions with mean vector 10× 1500 and covariance matrix σ2{15001T500ρ + (1−
ρ)I500} ⊗ I6. Here, σ2=4 is the common variance and ρ is the correlation between
gene expression levels. The above covariance structure implies that genes in the same
block are correlated, while genes in different blocks are independent. Finally, for
20% of the genes (300 randomly selected genes each for up- and down-regulated gene
groups), a true mean difference in expression ±δ between the two tissue classes was
added to the expression levels for the last 10 tissues.
We consider ρ=0.0 (independence), ρ=0.4 (moderate), ρ=0.6 (moderately strong),
ρ=0.8 (strong dependence), and δ=2 (moderate differential expression). For each set
of parameter values, 100 independent simulation experiments were conducted. We
fitted the extended random-effects model to the column-normalized data with g = 3
components. Given that there are 600 DE genes from a total of n=3000 genes in
each simulated data set, we obtained for each method the top ranked 600 genes and
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noted the proportion of null genes among them; that is, the false discovery proportion
(FDP), and the proportion of the 600 DE genes among them (the power). Figure 3
presents the results comparing the contrast method with the t-test, SAM, LIMMA,
and ODP. The proposed contrast method again outperforms the other approaches
with higher power and a markedly smaller error rate in FDP. It should be noted that
ODP was shown by [33] to outperform most of the leading methods for identifying
DE genes [35].
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Figure 3: Comparative study on a synthetic microarray data with correlated gene
expressions: true FDP among the top-ranked genes for Set 1: ρ=0.0, δ=2; Set 2:
ρ=0.4, δ=2; Set 3: ρ=0.6, δ=2; and Set 4: ρ=0.8, δ=2.
3.5 Simulation experiment 2: controlling the FDP
In this simulation experiment, we consider m=2 two classes of tissues and the same
setting as in Simulation experiment 1 above. Four sets of parameter values of (δ, ρ)
are considered: (δ=2, ρ=0.0), (δ=2, ρ=0.4), (δ=3, ρ=0.0), and (δ=3, ρ=0.4).
In this experiment we illustrate our contrast method, where the intent is to control
the FDR. One way to achieve this is to use the [19] procedure applied to the P -values.
In order to be able to compute a P -value for the test statistic Wj of our contrast
methods, we need to know its null distribution under the null hypothesis that the jth
gene is not DE. A rough approximation would be to take Wj as having a standard
normal distribution. We use an improved approximation by adopting a tv distribution
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with degrees of freedom ν estimated by fitting this t-distribution to some replicated
null values of Wj obtained by permuting the column labels as detailed in Section
2.2. Having obtained P -values for each gene, we can proceed as in [20] and convert
them to z-scores to which a mixture of two normals is fitted with the first component
corresponding to the null genes and the second component corresponding to the DE
genes. The (estimated) posterior probability τˆ 0(zj) that the jth genes belongs to the
first (null) component is the estimate of the local FDR. With each method, genes
having an estimated local FDR less than some threshold c0 (that is, τˆ 0(zj) < c0)
can be taken to be DE. The implied FDR and power can be estimated as outlined
in Section 2. In Table 2, the true FDP and power are presented. It can be seen that
the contrast method has high power when there is moderate differential expression or
moderate dependence. The other methods have less power (see Simulation experiment
1) and their results are not included in Table 2.
Table 2: Simulation study on controlling the FDR (contrast method)
Set Nr True FDP True FNDP True power
1 (δ=2, ρ=0) 502 0.0817 0.0556 0.7683
2 (δ=2, ρ=0.4) 541 0.0610 0.0374 0.8467
3 (δ=3, ρ=0) 601 0.0266 0.0062 0.9750
4 (δ=3, ρ=0.4) 609 0.0214 0.0017 0.9933
Note: The value Nr is the number of selected genes for differential expression
4 Discussion and Conclusion
We have presented a clustering-based contrast approach to draw inference on differ-
ences between classes using full gene-expression profiles. An extended random-effects
model is adopted for the clustering of gene-expression data, which allows for a direct
modelling of correlation among genes and within genes via correlated gene-specific
random effects. Our approach thus enables the partition of overall variation into
correlated random components and independent random noise. More importantly,
the predicted random effects have a meaningful interpretation and, together with the
fixed effects, they can be adopted to form a weighted contrast for assessing directly
the differential expression between tissue classes for each gene. The applicability of
the proposed method has been demonstrated using three published real data sets.
The results show that there is significant enrichment of highly-ranked genes that are
associated with particular biological functions such as cell division and cell prolifer-
ation. Empirical comparisons presented in the Results section demonstrate that the
proposed inference method, with the use of full gene-expression profiles, has higher
power to detect DE genes and outperforms multiple hypothesis testing approaches.
In applications where the attempt is to identify marker genes for accurate clas-
sification of disease subtypes [30], simply picking the top-ranked genes may not be
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efficient as the selected genes could be highly correlated among themselves [36]. In-
cluding lots of these redundant genes may confuse classifiers, with the consequent
possibility of misleading classifications being made [2]. The proposed clustering-based
contrast approach opens up a new way within a minimum redundancy and maximum
relevance framework [36] to form a list of marker genes useful for better classifications
of disease phenotypes. As correlated genes are grouped into the same cluster, a few
top-ranked genes selected from each cluster may provide a more complementary list of
marker genes that capture broader characteristics of disease phenotypes. The relative
performance of this approach in constructing a classifier for the prediction of disease
subtypes will be pursued in future research.
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